Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-12.87

-8.63

-4.39

-0.16

Details

Expected EPS

-1.20034512

Actual EPS

-1.12645

Surprise EPS

0.07

Surprise Percent

+6.16%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -1.12645 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.